製品番号: HY-108610

Copy Link Print Information

(R)-Edelfosine

(別名: (R)-ET-18-OCH3)

カスタマーレビュー

Based on 1 Customer Validation

(R)-Edelfosine ((R)-ET-18-OCH3) is a ether lipid analog with anti-HIV and antineoplastic activity.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

純度: 99.9%
CAS 番号: 77286-66-9
分子式: C₂₇H₅₈NO₆P
分子量:523.73

保管条件:

Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month

(R)-Edelfosine 構造式

CAS 番号: 77286-66-9

容量

価格（税別）

在庫状況

数量

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性

製品説明

(R)-Edelfosine ((R)-ET-18-OCH3) is a ether lipid analog with anti-HIV and antineoplastic activity^[1].

HIV アイソフォーム固有の製品をすべて表示 :

Cellular Effect

Cell Line	Type	Value	Description	References
A549	GI₅₀	5.05 μM Compound: 1	Inhibitor activity against A549 (Human lung carcinoma)cell line with varying concentration of the drug for 72 hrs Inhibitor activity against A549 (Human lung carcinoma)cell line with varying concentration of the drug for 72 hrs	[PMID: 8765506]
AMML	IC₅₀	3.3 μM Compound: 1	Compound was tested for the inhibition of AMML (acute myelomonocytic leukemia) Compound was tested for the inhibition of AMML (acute myelomonocytic leukemia)	[PMID: 3761322]
CML/BC	IC₅₀	1.5 μM Compound: 1	Compound was tested for the inhibition of CML/BC(chronic myeloid leukemia, blast crisis) Compound was tested for the inhibition of CML/BC(chronic myeloid leukemia, blast crisis)	[PMID: 3761322]
Glioblastoma cell line	IC₅₀	20 μM Compound: 1	Compound was tested for the inhibition of glioblastoma Compound was tested for the inhibition of glioblastoma	[PMID: 3761322]
HL-60	IC₅₀	2.5 μM Compound: 1	Compound was tested for the inhibition of human HL60 Leukemia Compound was tested for the inhibition of human HL60 Leukemia	[PMID: 3761322]
HT-29	GI₅₀	2.2 μM Compound: 1	Inhibitor activity against HT-29 (Human colon carcinoma)cell line with varying concentration of the drug for 72 hrs Inhibitor activity against HT-29 (Human colon carcinoma)cell line with varying concentration of the drug for 72 hrs	[PMID: 8765506]
L1210	GI₅₀	10.99 μM Compound: 1	Inhibitor activity against L1210/vmdr (transfected with a plasmid containing mdr1) cell line with varying concentration of the drug for 72 hrs Inhibitor activity against L1210/vmdr (transfected with a plasmid containing mdr1) cell line with varying concentration of the drug for 72 hrs	[PMID: 8765506]
L1210	GI₅₀	3.32 μM Compound: 1	Inhibitor activity against L1210 (murine leukemia )cell line with varying concentration of the drug for 72 hrs Inhibitor activity against L1210 (murine leukemia )cell line with varying concentration of the drug for 72 hrs	[PMID: 8765506]
Lewis lung carcinoma cell line	GI₅₀	30.24 μM Compound: 1	Inhibitor activity against Lewis lung (murine lung carcinoma)cell line with varying concentration of the drug for 72 hrs Inhibitor activity against Lewis lung (murine lung carcinoma)cell line with varying concentration of the drug for 72 hrs	[PMID: 8765506]
MCF7	GI₅₀	30.35 μM Compound: 1	Inhibitor activity against MCF-7/Adr (Human colon carcinoma)cell line with varying concentration of the drug for 72 hrs Inhibitor activity against MCF-7/Adr (Human colon carcinoma)cell line with varying concentration of the drug for 72 hrs	[PMID: 8765506]
MCF7	GI₅₀	9.66 μM Compound: 1	Inhibitor activity against MCF-7(Human breast carcinoma)cell line with varying concentration of the drug for 72 hrs Inhibitor activity against MCF-7(Human breast carcinoma)cell line with varying concentration of the drug for 72 hrs	[PMID: 8765506]
NSCLC	IC₅₀	21 μM Compound: 1	Compound was tested for the inhibition of non- small cell lung cancer Compound was tested for the inhibition of non- small cell lung cancer	[PMID: 3761322]
P388	GI₅₀	4.33 μM Compound: 1	Inhibitor activity against P388 (murine leukemia )cell line with varying concentration of the drug for 72 hrs Inhibitor activity against P388 (murine leukemia )cell line with varying concentration of the drug for 72 hrs	[PMID: 8765506]
P388	GI₅₀	6.39 μM Compound: 1	Inhibitor activity against P388/Adr (murine leukemia )cell line with varying concentration of the drug for 72 hrs Inhibitor activity against P388/Adr (murine leukemia )cell line with varying concentration of the drug for 72 hrs	[PMID: 8765506]
RBL-2H3	IC₅₀	7.1 μM Compound: 1	Inhibition of rat RBL2H3 cell granulation assessed as reduction of beta hexasaminidase release Inhibition of rat RBL2H3 cell granulation assessed as reduction of beta hexasaminidase release	[PMID: 20153565]
Small cell lung cancer cell line	IC₅₀	24 μM Compound: 1	Compound was tested for the inhibition of small cell lung cancer Compound was tested for the inhibition of small cell lung cancer	[PMID: 3761322]

化学情報

CAS 番号 77286-66-9
性状 Solid
分子量 523.73
分子式 C₂₇H₅₈NO₆P
Color White to off-white
SMILES

CCCCCCCCCCCCCCCCCCOC[C@@H](OC)COP(OCC[N+](C)(C)C)([O-])=O
別名

(R)-ET-18-OCH3
輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Powder	-20°C	3 years
In solvent	-80°C	6 months
	-20°C	1 month

溶剤 & 溶解度

体外:

H₂O : 10 mg/mL (19.09 mM; Need ultrasonic)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

1.9094 mL

9.5469 mL

19.0938 mL

5 mM

0.3819 mL

1.9094 mL

3.8188 mL

10 mM

0.1909 mL

0.9547 mL

1.9094 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

純度とドキュメンテーション

バッチを選択:

純度: 99.98%

Assay: 99.98%

ee.: 99.98%

データシート (262 KB)
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
COA (2659 KB)
元素分析報告書 (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
取扱説明書 (2659 KB)

参考文献

[1]. Xie X, et al. Interdigitation of bilayers from ether lipid analogs: (R)-PAF, (R)-Lyso-PAF and the antineoplastic (R)-ET-18-OMe. Biochim Biophys Acta. 1996 Aug 14;1283(1):111-8. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
H₂O	1 mM	1.9094 mL	9.5469 mL	19.0938 mL	47.7345 mL
	5 mM	0.3819 mL	1.9094 mL	3.8188 mL	9.5469 mL
	10 mM	0.1909 mL	0.9547 mL	1.9094 mL	4.7735 mL
	15 mM	0.1273 mL	0.6365 mL	1.2729 mL	3.1823 mL

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

Keywords

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

(R)-Edelfosine

Covalent Screening Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Covalent Screening Library Plus

Bioactive Compound Library

High-Throughput Bioactive Compound Library

Anti-Infection Compound Library

Anti-Cancer Compound Library

Antiviral Compound Library

HIV アイソフォーム固有の製品をすべて表示

生物活性

化学情報

溶剤 & 溶解度

純度とドキュメンテーション

参考文献

Help & FAQs

Complete Stock Solution Preparation Table

(R)-Edelfosine

Covalent Screening Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Covalent Screening Library Plus

Bioactive Compound Library

High-Throughput Bioactive Compound Library

Anti-Infection Compound Library

Anti-Cancer Compound Library

Antiviral Compound Library

HIV アイソフォーム固有の製品をすべて表示

生物活性

化学情報

溶剤 & 溶解度

純度とドキュメンテーション

参考文献

Help & FAQs

Complete Stock Solution Preparation Table

(R)-Edelfosine 関連分類

HY-108610 関連分類